Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

GREY:TBPMQ - Post Discussion

Tetra Bio Pharma Inc > We shareholders have heard it all before , dreams !
View:
Post by SamV21 on Dec 27, 2022 10:48pm

We shareholders have heard it all before , dreams !

Qixleef needs min. another $500,000,000 before it is anything and another 5 to 10 years of research , by then there will be something else and Tetra will be left in the dust . Syqe already is approved in Canada for pain , more self promotion posted , thats all. nothing new , same old same old dreams !
Comment by Savage97 on Dec 27, 2022 11:27pm
LOL!  This poser clown actually thinks their still fooling people.  Get a grip and stop making money at any cost, there is a better way...TBP...just takes patience.  GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities